A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis

Mucosal Immunology

Volumn 5, Issue 6, 2012, Pages 670-680

  Kim, C J ^a   Nazli, A ^b   Rojas, O L ^a   Chege, D ^a   Alidina, Z ^b   Huibner, S ^a   Mujib, S ^a   Benko, E ^c   Kovacs, C ^b,c   Shin, L Y Y ^a   Grin, A ^a   Kandel, G ^a,d   Loutfy, M ^a,c,e   Ostrowski, M ^a,d   Gommerman, J L ^a   Kaushic, C ^b,c   Kaul, R ^a,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MAPLE LEAF MEDICAL CLINIC   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e WOMEN S COLLEGE HOSPITAL   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867939219     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.72     Document Type: Article

References (41)

1. Mehandru, S. et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200, 761-770 (2004). (Pubitemid 39299462)
2. Sankaran, S. et al. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodefi ciency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J. Virol. 82, 538-545 (2008). (Pubitemid 350309168)
3. Veazey, R. S. & Lackner, A. A. The gastrointestinal tract and the pathogenesis of AIDS. AIDS 12 (Suppl A), S35-S42 (1998).
4. Veazey, R. S. et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280, 427-431 (1998). (Pubitemid 28208163)
5. Epple, H. J. et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 58 , 220-227 (2009).
6. Ancuta, P. et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3 , e2516 (2008).
7. Ross, A. C. et al. Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy. J. Acquir. Immune. Defi c. Syndr. 49, 499-506 (2008).
8. Ross, A. C. et al. Relationship between infl ammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin. Infect. Dis. 49, 1119-1127 (2009).
9. Wallet, M. A. et al. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS 24, 1281-1290 (2010).
10. Chege, D. et al. Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy. AIDS 25, 741-749 (2011).
11. Gordon, S. N. et al. Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodefi ciency virus-infected sooty mangabeys. J. Immunol. 179, 3026-3034 (2007).
12. Pandrea, I. V. et al. Acute loss of intestinal CD4+ T cells is not predictive of simian immunodefi ciency virus virulence. J. Immunol. 179, 3035-3046 (2007).
13. Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371 (2006). (Pubitemid 44924494)
14. Epple, H. J. et al. Acute HIV infection induces mucosal infi ltration with CD4+ and CD8+ T cells, epithelial apoptosis, and a mucosal barrier defect. Gastroenterology 139, 1289-1300 (2010).
15. Nazli, A. et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 6, e1000852 (2010).
16. Hofer, U. et al. Inadequate clearance of translocated bacterial products in HIV-infected humanized mice. PLoS Pathog. 6, e1000867 (2010).
17. Estes, J. D. et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodefi ciency virus infections. PLoS Pathog. 6, e1001052 (2010).
18. Brenchley, J. M. et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112, 2826-2835 (2008).
19. Ye, P. et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25, 335-340 (2001). (Pubitemid 32918915)
20. Kader, M. et al. Alpha4(+)beta7(hi)CD4(+) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection. Mucosal Immunol. 2, 439-449 (2009).
21. Sonnenberg, G. F., Fouser, L. A. & Artis, D. Border patrol: regulation of immunity, infl ammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12, 383-390 (2011).
22. Pickert, G. et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206, 1465-1472 (2009).
23. Sugimoto, K. et al. IL-22 ameliorates intestinal infl ammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534-544 (2008). (Pubitemid 351206544)
24. Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K. & Sabat, R. IL-22 increases the innate immunity of tissues. Immunity 21, 241-254 (2004). (Pubitemid 39094053)
25. De Luca, A. et al. IL-22 defi nes a novel immune pathway of antifungal resistance. Mucosal Immunol. 3, 361-373 (2010).
26. Ota, N. et al. IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat. Immunol. 12, 941-948 (2011).
27. Trifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K. & Spits, H. Identifi cation of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 10, 864-871 (2009).
28. Eyerich, S. et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 119 , 3573-3585 (2009).
29. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. & Sallusto, F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10, 857-863 (2009).
30. de Jong, A., Pena-Cruz, V., Cheng, T. Y., Clark, R. A., Van Rhijn, I. & Moody, D. B. CD1a-autoreactive T cells are a normal component of the human alphabeta T cell repertoire. Nat. Immunol. 11, 1102-1109 (2010).
31. Guillot-Delost, M. et al. Human CD90 identifi es Th17/Tc17 T cell subsets that are depleted in HIV-infected patients. J. Immunol. 188, 981-991 (2012).
32. Bengsch, B., Seigel, B., Flecken, T., Wolanski, J., Blum, H. E. & Thimme , R. Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26). J. Immunol. 188, 5438-5447 (2012).
33. Sandler, N. G. et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J. Infect. Dis. 203, 780-790 (2011).
34. Monteiro, P. et al. Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin {beta}7. J. Immunol. 186, 4618-4630 (2011).
35. McKinnon, L. R. et al. Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. J. Immunol. 187, 6032-6042 (2011).
36. Klatt, N. R. et al. Loss of mucosal CD103 + DCs and IL-17 + and IL-22 + lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. advance online publication, 30 May 2012; doi:10/1038/mi.2012.38 (2012).
37. Fujita, H., Nograles, K. E., Kikuchi, T., Gonzalez, J., Carucci, J. A. & Krueger, J. G. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc. Natl Acad. Sci. USA 106 , 21795-21800 (2009).
38. Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009).
39. Favre, D. et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Transl. Med. 2, 32ra36 (2010).
40. Hartigan-O 'Connor, D. J., Abel, K., Van Rompay, K. K., Kanwar, B. & McCune, J. M. SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment. Sci. Transl. Med. 4, 136ra169 (2012).
41. Ciccone, E. J. et al. Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels. Mucosal. Immunol. 3, 172-181 (2010).